Metrics as leading indicators, not lagging readouts
Most sales reporting is backward-looking. How many deals closed? What was average selling price? How did we track against quota?
Useful — but those tell you what happened. Pipeline health metrics exist to tell you what's about to happen. That's the mindset shift. You're not building a report. You're building an early warning system.
The six core pipeline health metrics
Metric | What it measures | Warning sign |
|---|
Coverage ratio | Total open pipeline value divided by quota for the period. Most teams target 3–4x depending on win rates and deal complexity. | Below 3x leaves no margin for slippage. Above 5x often signals low-quality opps inflating the number. |
Stage conversion rates | How many opportunities successfully advance from one stage to the next. Drops at a specific stage point to a consistent breakdown there. | A sharp drop at any single stage — especially discovery-to-demo or proposal-to-close — needs immediate diagnosis. |
Average deal age by stage | How long deals sit at each stage versus the historical baseline. Set from win/loss data. | Any deal more than 1.5x the stage average without advancement requires active review. |
Pipeline velocity | (Opportunities × Avg deal value × Win rate) ÷ Avg sales cycle length. Captures overall momentum of the sales engine. | Velocity dropping signals a problem — which input changed tells you where to look. |
Activity and engagement signals | Actual buyer behavior: unique contacts touched, email reply rates, days since last inbound response, meeting frequency over 30 days. | No buyer response in 14+ days at a late stage is a red flag. It doesn't matter what the rep is reporting. |
Multi-threading score | Number of distinct stakeholders actively engaged on a deal. One of the strongest predictors of close. | Enterprise deals with fewer than three engaged contacts should be pulled into the next pipeline review. |
Secondary metrics worth watching
Metric | What it reveals |
|---|
Rep pipeline contribution | Whether each rep is generating their own pipeline or relying on inbound and SDR support. Reps who rarely self-source are more exposed when top-of-funnel slows. |
Creation vs. close ratio | How much new pipeline is being created each month against what's closing. If you're closing faster than you're creating, coverage will deteriorate even when the current quarter looks fine. |
Pipeline aging by rep | Which reps are holding onto deals too long without action — either because they're afraid to call them dead or because they can't see the problem. |
Metrics that mislead
Metric | Why it misleads |
|---|
Total pipeline value | The most used and most abused pipeline metric. On its own it says nothing about deal quality, buyer engagement, or realistic close probability. A pipeline full of old, wishful deals feels fine on paper. Until the quarter closes. |
Close date proximity without buyer evidence | A deal closing on the last day of the quarter with zero recent buyer activity isn't in the forecast — it's in optimism. Close dates set by reps without corresponding buyer commitments are noise, not signal. |
How to build a pipeline health dashboard
Dashboard layer | Metrics | Review cadence |
|---|
Headline | Coverage ratio, pipeline velocity | Weekly — manager level |
Diagnostic | Stage conversion trends, average deal age by stage | Weekly — manager level |
Deal-level | Activity signals, multi-threading scores — tied to specific opportunities needing review | Weekly — manager level |
Strategic | All six core metrics plus secondary metrics — used for resource decisions and forecast adjustments | Monthly — leadership level |
What to read next
Metrics tell you what's wrong. Inspection is how you fix it. Read Sales Pipeline Inspection: A Complete Guide → to turn these signals into a repeatable review process.
Backstory surfaces all six of these metrics automatically — from actual buyer activity data, not rep inputs. See your pipeline health in real time. Start with the Pipeline Health solution →
